We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Refine your search

Content type



7 results found


Faegre Baker Daniels LLP | USA | 21 Mar 2012

Supreme Court decides Sackett v. Environmental Protection Agency

On March 21, 2012, the U.S. Supreme Court decided Sackett v. Environmental Protection Agency, No. 10-1062, holding that a person who receives a compliance order from the Environmental Protection Agency under the Clean Water Act may bring a civil action under the Administrative Procedure Act to challenge the issuance of the order.


Faegre Baker Daniels LLP | USA | 1 Aug 2011

SEC proxy access rule vacated by D.C. Circuit Court

On July 22, 2011, the U.S. Court of Appeals for the D.C. Circuit vacated Securities and Exchange Commission Rule 14a-11


Faegre Baker Daniels LLP | USA | 26 May 2011

Supreme Court decides Chamber of Commerce v. Whiting

On May 26, 2011, the U.S. Supreme Court decided Chamber of Commerce v. Whiting, No. 09-115, holding that the federal Immigration Reform and Control Act (IRCA) does not expressly or impliedly preempt an Arizona statute that requires Arizona employers to use the federal E-Verify system to check the authorized status of workers and punishes the knowing or intentional employment of unauthorized workers by suspending or revoking a business's licenses to operate.


Faegre Baker Daniels LLP | USA | 29 Mar 2011

Supreme Court decides Astra USA v. Santa Clara County

On March 29, 2011, the U.S. Supreme Court decided Astra USA v. Santa Clara County, No. 09-1273, holding that Section 340B health care facilities may not bring suits to enforce ceiling-price contracts running between drug manufacturers and the Secretary of Health and Human Services.


Faegre Baker Daniels LLP | USA | 4 Aug 2010

Life sciences - FDA reform train is full steam ahead: CDRH lays tracks for 510(k) system changes

On August 4, 2010, FDA's Center for Devices and Radiological Health (CDRH) took the next step toward potentially vast reform of the 510(k) review process by releasing its preliminary internal evaluations and recommendations potentially one of the most wide-ranging and substantial sets of changes in recent memory.


Faegre Baker Daniels LLP | USA | 6 Oct 2008

Under the microscope, again: will Medicare pay for routine costs in clinical trials?

On September 29, 2008, CMS issued a Medicare Learning Network (MLN) Matters article entitled "Clarification of Medicare Payment for Routine Costs in a Clinical Trial."

Previous page 1 Next page